SCHEMBL30827981

SCHEMBL30827981

N#Cc1nnc(N2CCCC(N3CCN(C4COC4)C3=O)C2)nc1Cl

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 3/20 0.33
▸ JAK3 P52333 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27175834 1.00 BTK (0.33) BTKJAK3
SCHEMBL30827939 0.91 BTK (0.33) BTKJAK3
SCHEMBL30828005 0.91 BTK (0.33) BTKJAK3
SCHEMBL24832847 0.91 BTK (0.33) BTKJAK3
SCHEMBL24834047 0.91 BTK (0.33) BTKJAK3
SCHEMBL24833017 0.91 BTK (0.33) BTKJAK3
SCHEMBL30827944 0.91 BTK (0.33) BTKJAK3
SCHEMBL27175859 0.91 BTK (0.34) BTKJAK3
SCHEMBL30827916 0.90 HRH3 (0.33) BTKJAK3
SCHEMBL27175832 0.90 HRH3 (0.33) BTKJAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4342892-A1 BRUTON'S TYROSINE KINASE AND MUTANT DEGRADER, COMPOSITION AND APPLICATION THEREOF Hangzhou Healzen Therapeutics Co., Ltd. (CN) 2024-03-27 — — EP disclosed
Send feedback